Herceptin and chemo improves response rates without major adverse effects in HER2 breast cancer

April 21st, 2008 by admin

Women with a specially battleful modify of boob cancer seem to do meliorate if they are aerated with a compounded anthracycline and taxane chemotherapy program before surgery, unitedly with trastuzumab before and after surgery, according to results from the maximal multi-center effort to analyse this treatment. The trial, presented at the 6th dweller Breast person Conference in Berlin, showed that the women did not undergo some earnest side-effects, much as hunch problems, from the treatment.

Tags: , , , , , , ,

Posted in Cancer |

Related posts

Comments are closed.